Literature DB >> 8888202

Which cyclosporin formulation?

G Filler, J Ehrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8888202     DOI： 10.1016/S0140-6736(05)65317-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Generic immunosuppressants.

Authors:  Mara Medeiros; Julia Lumini; Noah Stern; Gilberto Castañeda-Hernández; Guido Filler
Journal:  Pediatr Nephrol       Date:  2017-07-21       Impact factor: 3.714

Review 2.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 3.  Switching between cyclosporin formulations. What are the risks?

Authors:  A J Olyaei; A M deMattos; W M Bennett
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

4.  The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring.

Authors:  Guido Filler; Janusz Feber
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

Review 5.  Calcineurin inhibitors in pediatric renal transplant recipients.

Authors:  Guido Filler
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.